Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Study of Lanreotide Autogel for the Treatment of Patients With Acromegaly in China

NCT05431803 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT05431803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05431803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Study of Lanreotide Autogel for the Treatment of Patients With Acromegaly in China
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
June 30, 2022
Completion date
December 13, 2024
Enrollment
129 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly